ISSN: 1859 - 2872
Assessment of cognitive impairment in patients with vascular risk factors at 108 Military Central Hospital
Main Article Content
Keywords
Tóm tắt
Objective: This study aimed to screen for cognitive impairment using the Mini-Mental State Examination (MMSE) scale in patients with vascular risk factors, such as hypertension, diabetes mellitus, dyslipidemia, and obesity. Subject and method: A total of 263 outpatients diagnosed with hypertension, diabetes, dyslipidemia, obesity, and/or a history of smoking were screened using the MMSE scale at 108 Military Central Hospital between March 2023 and October 2023. The study design was a prospective cross-sectional approach, with data analyzed using SPSS software. Result: Cognitive impairment was observed in 48% of the patients, predominantly in individuals over 60 years old. The prevalence of cognitive impairment increased with age and was significantly associated with vascular risk factors, including hypertension, diabetes, and dyslipidemia (p<0.05). Patients with a higher number of risk factors demonstrated increased cognitive impairment (p<0.05). Conclusion: There is a significant relationship between cognitive impairment, as assessed by the MMSE scale, and the presence of vascular risk factors. This study highlights the importance of early screening and intervention for cognitive decline in patients with comorbid vascular conditions.
Article Details
Các tài liệu tham khảo
2. Creavin ST, Wisniewski S, Noel-Storr AH et al (2016) Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database Syst Rev 2016(1):CD011145. doi:10.1002/14651858.CD011145.pub2.
3. Doan Vuong Diem Khanh, Vo Van Thang, Ho Dung et al (2015) Prevalence of dementia among the elderly and healthcare needs in an urban community of central Vietnam. Vietnam Journal of Public Health 3(1): 16-23.
4. Bich NN, Dung NTT, Vu T et al (2019) Dementia and associated factors among the elderly in Vietnam: A cross-sectional study. International Journal of Mental Health Systems. 13: 14-26. doi:10.1186/s13033-019-0314-76.
5. Prince M, Wimo A, Guerchet M et al (2015) World Alzheimer Report 2015: The Global Impact of Dementia: An Analysis of Prevalence, Incidence, Cost and Trends. Alzheimer’s Disease International (ADI).
6. Lê Văn Thính (2007) Sa sút trí tuệ nguyên nhân mạch máu: vai trò của tai biến nhồi máu não. Tai biến mạch máu não hướng dẫn chẩn đoán và xử trí. Nhà xuất bản Y học, Hà Nội, tr. 353-370.
7. Brookmeyer R, Evans DA, Hebert L et al (2011) National dementia prevalence of Alzheimer's disease in the United States. Alzheimer's & Dementia 7: 61-73.
8. Mathillas J, Lovhbm H, Gustafson Y (2011) Increasing dementia prevalence among the very old. Age and Ageing 40: 243-249.
9. Galdstein FC, Ashley AV, Endeshaw YW et al (2008) Effects of hypertension and hypercholesterolemia on cognitive function in patients with Alzheimer's disease. Alzheimer's Disease and Associated Disorders 22: 336-342.
10. Bermejo-Pareja F, Benito-León J, Louis ED et al (2010) Risk of incident dementia in drug-untreated arterial hypertension: A population-based study. Journal of Alzheimer's Disease 22: 949-958.
11. Dufouil C, Richard F, Fievet N et al (2005) APOE genotype, cholesterol levels, lipid-lowering treatment, and dementia: The Three-City Study. Neurology 64: 1531-1538.
12. Morley JE, Banks WA (2010) Lipids and cognition. Journal of Alzheimer's Disease 20: 734-747.
13. Akomolafe A, Beiser A, Meigs JB et al (2006) Diabetes mellitus and risk of developing Alzheimer's disease: Results from the Framingham Study. Archives of Neurology 63: 1551-1555.
14. Nooyens ACJ, Baan CA, Spijkerman AMW et al (2010) Type 2 diabetes and cognitive decline in middle-aged individuals. Diabetes Care 33: 1964-1969.
15. Meikel MM, Rosenberg PB, Tschanz J et al (2007) Vascular factors predict rate of progression in Alzheimer's disease. Neurology 60: 1850-1858.